Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: AstraZeneca to Cut 2,300 Sales Jobs as Research to Narrow

Interesting article. This line is noteworthy: "Analysts have speculated that Soriot, who joined the company in October, will need to make a big acquisition to jump- start growth at the company". How many other big pharma's are in similiar siituations?

Share
New Message
Please login to post a reply